TrialBMC pulmonary medicine2025

Efficacy and safety of combined nebulization of unfractionated heparin, acetylcysteine, budesonide and ipratropium bromide in hospitalised patients with COVID-19 pneumonia: a randomized controlled clinical trial.

Junhui Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.